962 related articles for article (PubMed ID: 34071409)
21. Sphingolipid modulation: a strategy for cancer therapy.
Delgado A; Fabrias G; Bedia C; Casas J; Abad JL
Anticancer Agents Med Chem; 2012 May; 12(4):285-302. PubMed ID: 21864240
[TBL] [Abstract][Full Text] [Related]
22. Dietary and Endogenous Sphingolipid Metabolism in Chronic Inflammation.
Norris GH; Blesso CN
Nutrients; 2017 Oct; 9(11):. PubMed ID: 29143791
[TBL] [Abstract][Full Text] [Related]
23. Sphingolipid homeostasis in the endoplasmic reticulum and beyond.
Breslow DK
Cold Spring Harb Perspect Biol; 2013 Apr; 5(4):a013326. PubMed ID: 23545423
[TBL] [Abstract][Full Text] [Related]
24. Direct chemical evidence for sphingolipid domains in the plasma membranes of fibroblasts.
Frisz JF; Lou K; Klitzing HA; Hanafin WP; Lizunov V; Wilson RL; Carpenter KJ; Kim R; Hutcheon ID; Zimmerberg J; Weber PK; Kraft ML
Proc Natl Acad Sci U S A; 2013 Feb; 110(8):E613-22. PubMed ID: 23359681
[TBL] [Abstract][Full Text] [Related]
25. Sphingolipids and neuronal degeneration in lysosomal storage disorders.
Grassi S; Chiricozzi E; Mauri L; Sonnino S; Prinetti A
J Neurochem; 2019 Mar; 148(5):600-611. PubMed ID: 29959861
[TBL] [Abstract][Full Text] [Related]
26. Cancer and sphingolipid storage disease therapy using novel synthetic analogs of sphingolipids.
Gatt S; Dagan A
Chem Phys Lipids; 2012 May; 165(4):462-74. PubMed ID: 22387097
[TBL] [Abstract][Full Text] [Related]
27. Sphingolipid trafficking and protein sorting in epithelial cells.
Aït Slimane T; Hoekstra D
FEBS Lett; 2002 Oct; 529(1):54-9. PubMed ID: 12354613
[TBL] [Abstract][Full Text] [Related]
28. Sphingolipid breakdown products: anti-proliferative and tumor-suppressor lipids.
Hannun YA; Linardic CM
Biochim Biophys Acta; 1993 Dec; 1154(3-4):223-36. PubMed ID: 8280742
[TBL] [Abstract][Full Text] [Related]
29. Neuronal sphingolipidoses: Membrane lipids and sphingolipid activator proteins regulate lysosomal sphingolipid catabolism.
Sandhoff K
Biochimie; 2016 Nov; 130():146-151. PubMed ID: 27157270
[TBL] [Abstract][Full Text] [Related]
30. Computational modeling of sphingolipid metabolism.
Wronowska W; Charzyńska A; Nienałtowski K; Gambin A
BMC Syst Biol; 2015 Aug; 9():47. PubMed ID: 26275400
[TBL] [Abstract][Full Text] [Related]
31. Biophysics of sphingolipids I. Membrane properties of sphingosine, ceramides and other simple sphingolipids.
Goñi FM; Alonso A
Biochim Biophys Acta; 2006 Dec; 1758(12):1902-21. PubMed ID: 17070498
[TBL] [Abstract][Full Text] [Related]
32. Chemical tools to investigate sphingolipid metabolism and functions.
Delgado A; Casas J; Llebaria A; Abad JL; Fabriás G
ChemMedChem; 2007 May; 2(5):580-606. PubMed ID: 17252619
[TBL] [Abstract][Full Text] [Related]
33. Sphingolipid transport in eukaryotic cells.
van Meer G; Holthuis JC
Biochim Biophys Acta; 2000 Jun; 1486(1):145-70. PubMed ID: 10856719
[TBL] [Abstract][Full Text] [Related]
34. Ceramidases, roles in sphingolipid metabolism and in health and disease.
Coant N; Sakamoto W; Mao C; Hannun YA
Adv Biol Regul; 2017 Jan; 63():122-131. PubMed ID: 27771292
[TBL] [Abstract][Full Text] [Related]
35. Tackling the biophysical properties of sphingolipids to decipher their biological roles.
Carreira AC; Ventura AE; Varela AR; Silva LC
Biol Chem; 2015 Jun; 396(6-7):597-609. PubMed ID: 25581755
[TBL] [Abstract][Full Text] [Related]
36. Sphingolipids in neuroinflammation: a potential target for diagnosis and therapy.
Lee JY; Jin HK; Bae JS
BMB Rep; 2020 Jan; 53(1):28-34. PubMed ID: 31818364
[TBL] [Abstract][Full Text] [Related]
37. Sphingolipids in mitochondria.
Hernández-Corbacho MJ; Salama MF; Canals D; Senkal CE; Obeid LM
Biochim Biophys Acta Mol Cell Biol Lipids; 2017 Jan; 1862(1):56-68. PubMed ID: 27697478
[TBL] [Abstract][Full Text] [Related]
38. Sphingolipids in inflammation: roles and implications.
Pettus BJ; Chalfant CE; Hannun YA
Curr Mol Med; 2004 Jun; 4(4):405-18. PubMed ID: 15354871
[TBL] [Abstract][Full Text] [Related]
39. New approaches to the study of sphingolipid enriched membrane domains: the use of electron microscopic autoradiography to reveal metabolically tritium labeled sphingolipids in cell cultures.
Dolo V; D'Ascenzo S; Sorice M; Pavan A; Sciannamblo M; Prinetti A; Chigorno V; Tettamanti G; Sonnino S
Glycoconj J; 2000; 17(3 -4):261-8. PubMed ID: 11201799
[TBL] [Abstract][Full Text] [Related]
40. Lipid membrane domains in cell surface and vacuolar systems.
Kobayashi T; Hirabayashi Y
Glycoconj J; 2000; 17(3 -4):163-71. PubMed ID: 11201787
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
